MiMedx Group, Inc. (MDXG)
4.545
+0.04
(+1.00%)
USD |
NASDAQ |
Aug 31, 16:00
4.545
0.00 (0.00%)
After-Hours: 20:00
MiMedx Group Cash from Operations (Annual) : 74.00M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 74.00M |
| December 31, 2024 | 66.20M |
| December 31, 2023 | 26.78M |
| December 31, 2022 | -17.89M |
| December 31, 2021 | -1.982M |
| December 31, 2020 | -30.26M |
| December 31, 2019 | -39.41M |
| December 31, 2018 | 35.80M |
| December 31, 2017 | 62.94M |
| December 31, 2016 | 25.80M |
| Date | Value |
|---|---|
| December 31, 2015 | 18.81M |
| December 31, 2014 | 16.80M |
| December 31, 2013 | -0.2855M |
| December 31, 2012 | -3.385M |
| December 31, 2011 | -6.665M |
| December 31, 2010 | -8.158M |
| March 31, 2010 | |
| March 31, 2009 | -8.556M |
| March 31, 2008 | -8.136M |
| March 31, 2007 | -0.3973M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Anika Therapeutics, Inc. | 11.19M |
| Perspective Therapeutics, Inc. | -82.48M |
| ABVC BioPharma, Inc. | -2.986M |
| Enovis Corp. | 217.29M |
| Edwards Lifesciences Corp. | 1.595B |